“I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals

•Availability of DAA medications in and of themselves is not enough to ensure people will come forward for HCV treatment.•Understanding the preferred models of HCV care for people who inject drugs can ensure adequate scale up of treatment.•Understanding the needs of those who have yet to engage in HCV care will be crucial in continuing the treatment momentum.